Save 20% on Press Releases and More with NNW Prime! Click to View Details
WednesdayMar 22, 2017 12:35 pm

NetworkNewsBreaks – Sequential Brands Group, Inc. (NASDAQ: SQBG) Names Replacement for Departing CEO; Shares Lower

Shares of Sequential Brands Group (NASDAQ: SQBG) are down 10% after the company this morning named Karen Murray as chief executive officer to replace Yehuda Shmidman, who is stepping down from his position at the company and as a member of the board of directors. Murray has also been appointed to serve as a director of the company. “Karen Murray has outstanding leadership skills and industry experience and she has demonstrated her ability to activate and grow successful brands. We are excited to have an executive of Karen’s caliber join and lead our team at Sequential to grow with us. …

Continue Reading

WednesdayMar 22, 2017 12:32 pm

NetworkNewsBreaks – SeeThruEquity Issues Update on FTE Networks, Inc. (FTNW), Increases PT to $2.75

SeeThruEquity has issued an update and increased the price target to $2.75 on shares of FTE Networks’ (OTCQX: FTNW) stock. The update follows the company’s March 9th announcement that it plans to acquire Benchmark Builders, Inc. in a $75 million cash and stock transaction that is expected to close in the second quarter of 2017. In February, FTE filed an application to uplist to the Nasdaq Capital Markets, which is cited in the update by SeeThruEquity as a reason to increase the company’s price target. If approved, being listed on the Nasdaq Capital Market would be a noteworthy development for…

Continue Reading

WednesdayMar 22, 2017 12:29 pm

NetworkNewsBreaks – United Health Products, Inc. (UEEC) Covered at SeeThruEquity

SeeThruEquity has issued a preliminary coverage report on United Health Products (OTCQB: UEEC). The report follows the company’s recently filed application with the FDA to expand use indications for its lead product candidate, Hemostyp®, an all-natural hemostatic agent that has demonstrated the ability to quickly control bleeding from open wounds and body cavities. Hemostyp® Topical Hemostatic Dressing is FDA approved as a Class 1 device and is sold in prescription and over-the-counter forms. If approved by the FDA, the indications for Hemostyp® would be expanded to include use in general surgery, opening a new form of revenue for the company.…

Continue Reading

WednesdayMar 22, 2017 12:27 pm

NetworkNewsBreaks – MGX Minerals (MGXMF) Takes Aim at Growing Lithium Market With Cheaper Extraction Process

MGX Minerals (OTC: MGXMF) holds the largest lithium portfolio in Canada and has its sights set on the booming global lithium market, projected to reach $5.87 billion by 2020. “Positive developments have made the company’s lithium operations a special point of interest. An important factor is the company’s engineering partner Purlucid Treatment Solutions, which has developed technologies representing a major step in the process of extracting lithium from petroleum brine water (petrolithium). MGX already holds the largest lithium portfolio in Canada, with its Sturgeon Lake property in Alberta and other lithium assets, and the company is the sole proprietary technology…

Continue Reading

WednesdayMar 22, 2017 12:24 pm

NetworkNewsBreaks – National Waste Management Holdings, Inc. (NWMH) Maintains Steady Focus on Expansion

National Waste Management Holdings (OTC: NWMH) has set what some would consider a lofty objective of four acquisitions per year. With an impressive track record of doing so, however, the management team at National Waste has demonstrated its ability to meet this goal and diversify its revenue streams. “These days, National Waste continues to press forward with an aggressive business model that calls for one acquisition per quarter by seeking out acquisitive opportunities in Upstate New York and Florida. To name a few, the company acquired both Sivart Services, a roll-off and compactor company in Worchester, NY, and Northeast Data…

Continue Reading

WednesdayMar 22, 2017 12:22 pm

NetworkNewsBreaks – Moleculin Biotech, Inc. (NASDAQ: MBRX) Shares Spike on Orphan Drug Designation for Annamycin

Moleculin Biotech (NASDAQ: MBRX) shares are 31% higher mid-morning after the company said it has received Orphan Drug Designation from the U.S. Food and Drug Administration (FDA) for Annamycin for the treatment of acute myeloid leukemia (AML). This designation will provide the company several benefits, such as tax credits for qualified clinical trials costs, exemptions from certain FDA application fees, and seven years of market exclusivity upon regulatory product approval. "We are pleased to report this key milestone and the FDA's decision to grant Annamycin orphan drug designation. We look forward to announcing additional milestones in regard to our clinical…

Continue Reading

WednesdayMar 22, 2017 11:18 am

NetworkNewsBreaks – TapImmune, Inc. (NASDAQ: TPIV) Announces Participation in Two Upcoming Investor and Industry Conferences

Clinical-stage immuno-oncology company TapImmune, Inc. (NASDAQ: TPIV) today announced plans to participate in two upcoming investor and industry conferences. First, Dr. Glynn Wilson, chairman and CEO of TapImmune, will be offering an overview of the company’s business, clinical pipeline and partnering opportunities for its proprietary PolyStart technology platform at the 5th Annual Cancer Biopartnering & Investment Forum hosted by Sachs Associates in New York City. Wilson’s presentation is scheduled for 10:35 am ET on Tuesday, March 28, 2017. The full presentation will be webcast live and archived for future viewing at http://tapimmune.com/events. Second, Dr. John Bonfiglio, president and chief operating…

Continue Reading

WednesdayMar 22, 2017 10:44 am

NetworkNewsBreaks – UniPixel, Inc. (NASDAQ: UNXL) Defies Market Slump; Shares Rise on Multi-Year Deal with Major PC Maker

Shares of UniPixel (NASDAQ: UNXL) are up more than 16% this morning after the company said it has entered into a long-term agreement with a major U.S.-based PC maker to supply XTouch touch screen sensors for multiple years. Per the agreement, the PC maker will supply rolling forecasts to UniPixel and will use its best commercial efforts to make the purchases outlined in the rolling forecasts. The company will reserve manufacturing capacity for the PC maker based off of the rolling forecasts. The agreement also permits the PC maker to request limited, exclusive early access to certain technology development advancements,…

Continue Reading

TuesdayMar 21, 2017 1:24 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on March 21, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: PULM 25.90% – News: Receives key patent from European Union HTBX 9.68% – News: Releases latest results from phase 2 trial of HS-110 in combination with nivolumab SPYR 9.09% – News: Issues shareholder update SPDL 7.76% – News: Enters digital marketing partnership with Mach One Media Group CATS 6.84% – News: Expands its OnTrak™-C coverage to Texas with leading insurance provider LOTE 5.97% – News: Appoints new CEO, plans first acquisition OWCP 5.38% –…

Continue Reading

TuesdayMar 21, 2017 1:10 pm

NetworkNewsBreaks – Cellectar Biosciences, Inc. (NASDAQ: CLRB) Obtains Patent for Use of CLR 124 in PET Imaging

Cellectar Biosciences (NASDAQ: CLRB) this morning said the United States Patent and Trademark Office has granted a method of use patent for CLR 124, the cancer imaging agent that utilizes the company’s proprietary phospholipid drug conjugate (PDC) delivery platform. The newly issued patent, titled “Phospholipid Ether Analogs as Agents for Detecting and Locating Cancer and Methods Thereof,” provides intellectual property protection through March 2, 2025. The patent outlines the use of CLR 124 in PET imaging to detect radiation-insensitive or chemotherapy-insensitive cancers and cancer metastases. Additionally, the patent provides coverage for the use of CLR 124 in identifying the location…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000